NewEdge Wealth LLC Purchases New Stake in National Health Investors, Inc. $NHI

Key Points

• NewEdge Wealth acquired 29,178 shares of National Health Investors in the second quarter, worth approximately $2.2 million. Institutional investors collectively own 62.51% of NHI.
• Analysts maintain a “Moderate Buy” consensus, with an average price target of $83.86, although several firms recently lowered their targets and Zacks downgraded the stock to “Strong Sell.”
• NHI reported quarterly EPS of $1.19 on $121.32 million in revenue and declared a $0.92 quarterly dividend, equivalent to a 5.0% yield. Shares opened at $73.91, below the consensus price target.

NewEdge Wealth LLC acquired a new position in National Health Investors, Inc. (NYSE:NHI - Free Report) in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 29,178 shares of the real estate investment trust's stock, valued at approximately $2,225,000. NewEdge Wealth LLC owned 0.06% of National Health Investors as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. BlackRock Inc. bought a new position in National Health Investors in the second quarter valued at approximately $665,997,000. State Street Corp lifted its stake in shares of National Health Investors by 5.0% in the 2nd quarter. State Street Corp now owns 2,023,381 shares of the real estate investment trust's stock valued at $143,651,000 after purchasing an additional 95,812 shares during the period. Principal Financial Group Inc. boosted its position in shares of National Health Investors by 2.0% in the 1st quarter. Principal Financial Group Inc. now owns 1,700,908 shares of the real estate investment trust's stock worth $137,537,000 after purchasing an additional 32,902 shares during the last quarter. Bank of New York Mellon Corp acquired a new stake in shares of National Health Investors during the second quarter worth $122,509,000. Finally, Geode Capital Management LLC grew its stake in shares of National Health Investors by 1.5% during the fourth quarter. Geode Capital Management LLC now owns 1,262,657 shares of the real estate investment trust's stock worth $96,443,000 after purchasing an additional 18,198 shares during the period. 62.51% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several research firms have weighed in on NHI. Truist Financial cut their target price on National Health Investors from $89.00 to $81.00 and set a "buy" rating on the stock in a research note on Friday, June 12th. BMO Capital Markets decreased their target price on National Health Investors from $90.00 to $80.00 and set an "outperform" rating for the company in a research report on Monday, June 15th. Wells Fargo & Company lowered their price target on National Health Investors from $84.00 to $79.00 and set an "equal weight" rating for the company in a research note on Monday, June 1st. Deutsche Bank Aktiengesellschaft cut their price target on shares of National Health Investors from $85.00 to $80.00 and set a "hold" rating on the stock in a research report on Thursday, June 25th. Finally, Zacks Research cut shares of National Health Investors from a "hold" rating to a "strong sell" rating in a report on Thursday, June 25th. Five investment analysts have rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $83.86.

National Health Investors Trading Down 0.2%

Shares of NYSE:NHI opened at $73.91 on Friday. The firm has a market cap of $3.63 billion, a price-to-earnings ratio of 21.36, a PEG ratio of 3.40 and a beta of 0.51. National Health Investors, Inc. has a 12 month low of $67.94 and a 12 month high of $91.38. The company's fifty day simple moving average is $75.45 and its 200 day simple moving average is $79.13. The company has a quick ratio of 6.78, a current ratio of 6.78 and a debt-to-equity ratio of 0.81.

National Health Investors (NYSE:NHI - Get Free Report) last released its earnings results on Monday, August 10th. The real estate investment trust reported $1.19 earnings per share (EPS) for the quarter. The firm had revenue of $121.32 million during the quarter. National Health Investors had a return on equity of 10.89% and a net margin of 38.56%.National Health Investors's revenue for the quarter was up 1.6% on a year-over-year basis. During the same quarter last year, the company posted $1.22 EPS. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. As a group, research analysts forecast that National Health Investors, Inc. will post 4.77 EPS for the current fiscal year.

National Health Investors Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 6th. Stockholders of record on Wednesday, September 30th will be paid a dividend of $0.92 per share. This represents a $3.68 dividend on an annualized basis and a dividend yield of 5.0%. The ex-dividend date is Wednesday, September 30th. National Health Investors's dividend payout ratio is currently 108.67%.

Insider Activity

In related news, Director Robert A. Mccabe, Jr. purchased 890 shares of National Health Investors stock in a transaction that occurred on Monday, June 15th. The stock was purchased at an average cost of $71.65 per share, with a total value of $63,768.50. Following the completion of the transaction, the director owned 44,159 shares of the company's stock, valued at approximately $3,163,992.35. This trade represents a 2.06% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO D. Eric Mendelsohn purchased 1,500 shares of the firm's stock in a transaction on Friday, June 5th. The stock was bought at an average price of $68.84 per share, with a total value of $103,260.00. Following the completion of the purchase, the chief executive officer owned 133,316 shares of the company's stock, valued at approximately $9,177,473.44. This represents a 1.14% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. 2.70% of the stock is owned by company insiders.

National Health Investors Profile

National Health Investors, Inc NYSE: NHI is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company's portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.

Want to see what other hedge funds are holding NHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National Health Investors, Inc. (NYSE:NHI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source